2025 Pharmaceutical Intermediates Industry Trends Report: Long-Term Outlook Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Pharmaceutical Intermediates Market Size By 2025?
The size of the pharmaceutical intermediates market has seen considerable growth in past years. The market value is set to increase from $33.37 billion in 2024 to $35.35 billion in 2025, implying a compound annual growth rate (CAGR) of 5.9%. Factors contributing to growth during the historic period include advancements in chemical synthesis, the evolution of drug development, heightened market demand and growth, research and development, and regulatory compliance.

How Big Is the Pharmaceutical Intermediates Market Size Expected to Grow by 2029?
The market size for pharmaceutical intermediates is poised for substantial expansion in the coming years. By 2029, it is predicted to reach $47.01 billion with a compound annual growth rate (CAGR) of 7.4%. The predicted growth for the forecasted period is attributed to factors such as innovation in biopharmaceuticals, the evolution of precision medicine, adoption of green chemistry principles, tailored intermediates and trends in pharmaceutical outsourcing. Some key trends for this period would include the adoption of continuous flow chemistry, expanded use of automation and robotics, employment of nanotechnology, advancements in biocatalysis and enzyme engineering, and a focus on strategic supply chain management.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-intermediates-global-market-report

Which Key Market Drivers Powering Pharmaceutical Intermediates Market Expansion and Growth?
The growing incidence of chronic illnesses is anticipated to spur the expansion of the pharmaceutical intermediates market. Chronic illnesses are long-term health conditions that can potentially deteriorate over time, typically lasting for three months or more. The increasing cases of chronic afflictions are primarily attributed to factors such as an aging population, lifestyle modifications, swift urbanization, and a lack of preventative steps. Pharmaceutical intermediates are integral in the creation and production of drugs used to treat chronic illnesses. For example, the US-based National Institute of Health reported in March 2022 that the rate of chronic kidney diseases will be at 13.4%. Moreover, between 4.902 and 7.083 million individuals might need renal replacement therapy due to end-stage kidney disease (ESKD). The precise application of pharmaceutical intermediates can significantly mitigate the rise in chronic conditions. Hence, the increasing prevalence of chronic diseases is fuelling the growth of the pharmaceutical intermediates market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11948&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Pharmaceutical Intermediates Market?
Prominent players in the pharmaceutical intermediates market are introducing cutting-edge product lines such as API Intermediates, in an effort to boost their financial gains in the industry. API intermediates are chemical entities utilized in the creation of active pharmaceutical ingredients (APIs). For instance, a pharmaceutical firm based in China, Huateng Pharmaceutical Co. Ltd., inaugurated its innovative product range known as Gastrointestinal API Intermediates in October 2023. These intermediates serve as essential components for the pharmaceutical ingredients found in medications for the digestive system. They play a critical role in the manufacturing of drugs aimed at treating disorders associated with the gastrointestinal tract, including laxatives, 5-HT3 receptor antagonists, H2-receptor antagonists, and proton pump inhibitors.

What Are the Emerging Segments in the Pharmaceutical Intermediates Market?
The pharmaceutical intermediates market covered in this report is segmented -

1) By Product: Chemical Intermediate, Bulk Drug Intermediate, Other Products
2) By Category: Branded Drug Intermediate, Generic Drug Intermediate
3) By Application: Analgesics, Anti-Infective Drugs, Cardiovascular Drugs, Oral Antidiabetic Drugs, Antimicrobial Drugs, Other Applications
4) By End-User: Biotech And Pharma Companies, Research Institutions, Other End-Users

Subsegments:
1) By Chemical Intermediate: Active Pharmaceutical Ingredients (APIs), Specialty Chemicals
2) By Bulk Drug Intermediate: Precursor Chemicals, Intermediate Drug Substances
3) By Other Products: Biopharmaceutical Intermediates: Excipients, Pharmaceutical Additives

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11948&type=smp

Who Are the Global Leaders in the Pharmaceutical Intermediates Market?
Major companies operating in the pharmaceutical intermediates market include BASF SE, Sanofi SA, Thermo Fisher Scientific Inc, Meck KGaA, Dishman Carbogen Amcis Ltd, Evonik Industries AG, Arkema Inc., Lonza Group AG, Wuxi AppTec co. Ltd, Aurobindo Pharma Lmited., Lianhe Chemical Technology Co. Ltd., Cambrex Corporation, Vertellus Holdings LLC., Hovione LLC, Hikal Ltd., Codexis Inc., Aceto Corporation, Interchem Corporation, Midas Pharma GmbH, Arbiom, Dextra Laboratories Ltd., A. R. Life Sciences, Ingenza Ltd, Chiracon GmbH, Dyadic International Inc., Elam Pharma Pvt Ltd, Yin-sheng Bio-tech Co. Ltd., Green Vision Life Sciences, Sibylla Biotech s.r.l., Pfizer CentreOne

Which are the Top Profitable Regional Markets for the Pharmaceutical Intermediates Industry?
North America was the largest region in the pharmaceutical intermediates market in 2024. The regions covered in the pharmaceutical intermediates market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11948

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.